Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference, Conference Call, Webcast, Advisory, Business Update

Global Blue Announces Date for Q1 2022/23 Results


Global Blue Group Holding AG (NYSE: GB and GB.WS) (NYSE:GB) today announced that it will release its financial results for the first fiscal quarter ended June 30, 2022, on September 2, 2022, before the market opens.

The earnings release will include Management's Discussion and Analysis of Financial Position and Results of Operations in addition to the accompanying unaudited condensed Consolidated Interim Financial Statements and the investor presentation.

An audio recording of commentary on the results by Jacques Stern, Chief Executive Officer, and Roxane Dufour, Chief Financial Officer, will also be made available.

These materials can be accessed via the Investor Relations section of the company's website at Global Blue Group Holding AG - Investor Relations.

ABOUT GLOBAL BLUE

Global Blue offers innovative solutions in three different fields:

In addition, our data and advisory services offer a strategic advisory to help retailers identify opportunities for growth, while our shopper experience and engagement solutions provide data-driven solutions to increase footfall, convert footfall to revenue and enhance performance.

Pre-pandemic figures FY 2019-20.


These press releases may also interest you

at 18:03
Revenue Revenue for the year was $238.5, down $1.4 from sales of $239.9 in 2022. The Company's  sales were flat when compared to 2022 and 2021 included a fifteen month period due to the accounting change from September 30 to December 31. Twelve-month...

at 18:02
Buhler Industries Inc. ("Buhler Industries or the Company"), the manufacturer of Versatile and Farm King brands of farm equipment, has made operational restructuring changes in the first quarter of 2024 that is expected to result in significant full...

at 18:01
Buhler Versatile Inc. ("Versatile"), a wholly owned subsidiary of Buhler Industries Inc. (Buhler Industries or the Company), has received $14.4 million Canadian ($10.7 million USD) in additional long term financing from its majority owner Ba?ak...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:52
In view of the passing of Thomas G. Kamp, a Director on the Board of Directors of The Taiwan Fund, Inc. (TWN) (the "Fund"), on March 20, 2024, the Board has approved amending the size of the Board to four Directors.  The Board will consider later in...

at 17:46
iA Financial Group today announces that the Annual Shareholder Meeting of iA Financial Corporation Inc. ("iA Financial Corporation") and the Annual Meeting of the Sole Common Shareholder and of the Participating Policyholders of Industrial Alliance...



News published on and distributed by: